Bank Of Montreal Cyma Bay Therapeutics, Inc. Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$3.22 - $6.27 $181,208 - $352,850	56,276 New	56,276 $352,000
Q1 2022 May 12, 2022	SELL	$2.77 - $3.64 $46,824 - $61,530	-16,904 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$3.23 - $4.6 $6 - $9	-2 Reduced 0.01%	16,904 $56,000
Q3 2021 Nov 12, 2021	BUY	$3.47 - $4.42 $58,663 - $74,724	16,906 New	16,906 $65,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.